AzTrials
AzTrials

Anger ProblemsCARTNCT06609330

Treatment of Chronic Anger and Aggression Following Military-Related Betrayal

A study testing Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART) in people with Anger Problems and Aggression, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a treatment designed to deal with anger and aggression from a past betrayal will work. The study will be done on active duty military service members and veterans aged 18 or older. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Anger Problems, Aggression
What is being tested?
Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
17 Mar 2025to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult active duty military service members and veterans aged 18 or older.
  • Endorses a history of military-related betrayal (on the Modified Moral Injury Questionnaire)
  • Endorses problematic anger in the past month (as evidenced by a score of 12 or above on the Dimensions of Anger Reactions; DAR-5)
  • Engaged in at least 1 self-reported act of aggression in the past 1 month (on the Overt Aggression Scale-Modified; OAS-M)

Who cannot join

  • Participated in an anger management or trauma-focused intervention within the past 3 months as assessed by self-report.
  • Acute suicidality requiring immediate intervention, such as hospitalization as assessed by the Depressive Symptoms Index-Suicidality Subscale (DSI-SS) combined with follow up clinical interview for elevated scores.
  • Is currently homicidal with plans and intent to hurt a specific person and requiring immediate intervention as measured by self-report and follow-up with clinician if screened positive.
  • Moderate to severe brain injury as measured by inability to comprehend the informed consent document or baseline assessments.
  • Has severe alcohol consumption patterns as evidenced by a score of 19 or above on the Alcohol Use Disorders Identification Test (AUDIT).
  • Experiencing active psychosis or mania as measured by the Prodromal Questionnaire-Brief Version and the Mood Disorders Questionnaire.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Vanessa Jacoby, PhD contact

(254) 289-3468

jacobyv@uthscsa.edu

Alan Peterson, PhD contact

(210) 562-6700

petersona3@uthscsa.edu

United States1 site, 1 recruiting
  • Carl R. Darnall Army Medical Center (CRDAMC) at Fort Cavazos

    Fort Cavazos, Texas, 76554

    Vanessa Jacoby, PhD, 254-289-3468, jacobyv@uthscsa.edu

    Recruiting

Other trials in United States

About this study

Official title: Assessment and Treatment of Chronic Anger and Aggression Following Military-Related Interpersonal and Institutional Betrayal: A Pilot Investigation

The goal of this clinical trial is to learn if a treatment designed to deal with anger and aggression from a past betrayal will work. The study will be done on active duty military service members and veterans aged 18 or older. The main questions it aims to answer are:

  • Will participants be satisfied with the treatment, and is the treatment feasible to do in a military outpatient setting
  • Will the treatment help with anger and aggression issues.
Read more

Researchers will compare differences in groups that have different wait times (2-, 3-, or 4-weeks).

Participants will complete surveys before, during and after the treatment. The treatment will be 14 modules given twice a week. About 1 month after treatment ends, surveys will be taken again.

Read the detailed description

Participants will undergo the study procedures described below. The preferred method of assessment and treatment is face-to-face in the STRONG STAR offices at Fort Cavazos. However, there may be circumstances when participants can complete the treatment through telebehavioral health (i.e., by phone or using a HIPAA-compliant video calling platform like Zoom). Decisions will be made on a case-by-case basis as issues arise for individuals (e.g., childcare) and in discussion with the treatment team. If participants do not have internet access they may need to complete assessments in person at the STRONG STAR office or by phone.

  • During the wait time:
  • Complete a 5-10 minute assessment twice per week (Monday/Thursday or Tuesday/Friday) to assess level of anger, aggression, and interactions with others since last assessment.
  • The assigned therapist will call participants once a week for a 10-minute, check-in.
  • At the end of participants' assigned wait time, they will complete an assessment of level of anger, aggression, interactions with others, mental, and physical health.
  • During treatment:
  • Begin treatment within 1 week of last wait time assessment.
  • Participate in 7-24 (average 14) one-hour bi-weekly (Monday/Thursday or Tuesday/Friday) CART sessions.
  • Prior to each session, participants will complete the same 5-10 minute assessment to assess level of anger, aggression, and interactions with others since last assessment.
  • At the final treatment session, participants will be scheduled to complete a 1-month follow-up assessment.
  • For follow-up:
  • Complete a 1-month follow up assessment between 4-8 weeks after the final treatment session.
  • Participants will be sent a link to complete the follow-up assessment.
  • Complete the same questionnaires completed at pre-treatment plus an exit interview and a brief satisfaction survey.
Being tested
Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART)
Keywords
Anger management, Military-related betrayal, Deficit of trust
Medical subject headings
Aggression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART)Behavioural

    Also called CART

    Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART), a novel intervention for reducing chronic anger and aggression and improving interpersonal relationships, in military personnel who have experienced military-related betrayal delivered in 14 treatment modules twice a week.

Study groups in NCT06609330
Study groupRoleWhat they receive
2-week wait time groupExperimentalThis group is randomized to a 2-week wait time prior to treatment with CART
Receives: Behavioral: Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART)
3-week wait time groupExperimentalThis group is randomized to a 3-week wait time prior to treatment with CART
Receives: Behavioral: Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART)
4-week wait time groupExperimentalThis group is randomized to a 4-week wait time prior to treatment with CART
Receives: Behavioral: Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Successful recruitment

    Number of eligible referrals that are recruited, enrolled into the study and randomized to treatment

    Measured: Study start to last subject enrolled, approximately 1 year

  2. Client satisfaction survey (CSQ-8)

    The survey will assess participant acceptability using the CSQ-8, an 8-item self-report measure designed to assess client satisfaction. Each question is answered on a 4-point scale with a possible range of scores between 8-32. A higher score indicates a higher level of overall satisfaction. Mean scores will be used to determine participant satisfaction.

    Measured: 1 month after study end ( at approximately 11-18 weeks)

  3. Overt Aggression Scale-Modified (OAS-M)

    A 17-item measure that assesses frequency of different aggression acts in outpatient settings, including verbal and physical aggression against self, other, and objects. The OAS-M is scored by summing the instances of aggression since the last assessment. The OAS-M had been administered as an interview as well as self-report and will be administered as a self-report in this study, consistent with past aggression research with veterans (Miles, Kent et al., 2020). The score is calculated using a sum total of all instances of aggression. Higher scores indicate a greater frequency of aggressive behaviors.

    Measured: Baseline to 1 month post treatment (approximately 11-18 weeks)

  4. Inventory of Interpersonal Problems-Short Version (IIP-32)

    A 32-item self-report assessment designed to measure interpersonal functioning. Items are scored on a five-point scale from 0 (not at all) to 4 (extremely) in response to the stem: "How much have you been distressed by this problem?" There are 8 factors and a total score. The 8 factors are: hard to be assertive, hard to be sociable, hard to be supportive, too dependent, too caring, too aggressive, hard to be involved and too open. The possible total score ranges from a T-score are 0-100. T-scores that are higher than 60 are above average and T-scores 70 or higher suggest significant interpersonal difficulty.

    Measured: Baseline to 1 month post treatment (approximately 11-18 weeks)

  5. State Trait Anger Expression Inventory-2 (STAXI-2)

    A 57-item inventory which measures the frequency and intensity of anger as an emotional state. There are 6 scales, 5 subscales, and an Anger Expression Index (total anger expression). The State Anger scale (15 items) measures anger intensity as a momentary emotional state, while the Trait Anger scale (10 items) measures the disposition to experience angry feelings as a personality-like trait over lengthy time periods (i.e., the individual's disposition to become angry or angry temperament). The Anger Expression scale (16 items) and the Anger Control scale (16 items) measure four anger-related trait dimensions. Ratings of items are on a 4-point response scales that measure state anger (intensity) as well as trait anger (frequency). The possible total range is a T-score from 0 to 100. Individuals with anger scores higher than the 75-percentile experience and/ or express angry feelings to a degree that may interfere with optimal functioning.

    Measured: Baseline to 1 month post treatment (approximately 11-18 weeks)

Secondary outcomes (6)
  1. Rate of protocol completion

    The 14 modules may be completed within a 7-14 week time period by each participant.

    Measured: Treatment end (Approximately 7-14 weeks)

  2. Number of modules completed

    A count of how many of the 14 modules are completed

    Measured: Baseline to end of treatment (approximately 7-14 weeks)

  3. Brief Inventory of Psychosocial Functioning (B-IPF)

    A 7-item, self-report measures of psychosocial functioning in seven life domains: romantic relationship, relationship with children, family relationships, friendships and socializing, work, training and education, and activities of daily living. In each area on a 7-point scale ranging from 0 = Not at all to 6 = Very much. The B-IPF total score is calculated by summing the scale items completed by the respondent, dividing by the maximum possible score based upon the number of applicable items and multiplying by 100. Higher scores indicate greater psychosocial dysfunction.

    Measured: Baseline to 1 month post treatment (approximately 11-18 weeks)

  4. Dimensions of Anger Reactions (DAR-5)

    A 5-item self report measure that assesses anger frequency, intensity, urge to act aggressively and impact on social functioning over the past 1 month. Respondents are asked how impacted they have been on a five-point Likert scale ranging from 0-5. Items are summed to provide a total severity score (range 5-25). A score of 12 or higher indicates problematic anger.

    Measured: Baseline to 1 month post treatment (approximately 11-18 weeks)

  5. Revised Conflict Tactics Scale Short Form (CTS-2)

    The CTS-2 poses 39 questions to assess five tactics used when conflict occurs within the relationships of dating, cohabitating, or marital couples. For this study, only the Physical Assault and Psychological Aggression subscales (20 items) of the CTS-2 will be used, broadening the assessment of conflict to query interpersonal conflict among friends, colleagues, and acquaintances as well as the family. The scoring range is: 0-6, Two Subscales: 1) Psychological Aggression: 1-8 2) Physical Assault: 9-20, Special Coding: Sum midpoints of chosen response option: Never-0, Once-1, Twice-2, 3-5 times -4 , 6-10 times-8, 11-20 times-15, greater than 20 times-25. For item scoring range 0-25, Psychological Aggression scoring range 0-200, Physical Assault scoring range 0-300. The higher scores indicate higher levels of Psychological Aggression and Physical Assault.

    Measured: Baseline to 1 month post treatment (approximately 11-18 weeks)

  6. Trauma-Related Anger Scale (TRAS)

    A 19-item self report measure to assess anger in the context of posttraumatic stress. Participants are asked to rate each item from Not at all true (0) to ;Definitely True(3) both prior to their traumatic event, and within the past two weeks. The scoring range for the items summed to provide a total severity score is 0-57. Items 1-7 = Anger giving a sense of control or energy, Items 8-14 = thought and emotional avoidance relating to anger, Items 15-17 = anger in response to threat, Items 18-19 = anger in response to pity. The higher score means greater anger in the context of PTSD. Higher scores in past two weeks, as compared with pre-trauma scores, indicate more severe trauma-related anger.

    Measured: Baseline to 1 month post treatment (approximately 11-18 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2024
  2. Study start17 Mar 2025
  3. Primary completionNov 2026 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Upon enrollment into the study, participants will begin with a minimal contact wait condition followed by randomization to different wait times (2-, 3-, or 4-weeks)
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06609330
Sponsor's protocol ID
20230329HU
Other IDs
W81XWH-22-2-0085
Acronym
CART
Status last verified
Mar 2026
First submitted
14 Aug 2024
Last updated
1 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: At the conclusion of the study all data will be stripped of identifiers. De-identified (anonymized) data will be maintained indefinitely in the STRONG STAR Repository. Identifiable data from participants who signed the consent to have their data placed in the STRONG STAR Repository will be maintained under the UTHSCSA IRB-approved Repository protocol indefinitely.

Questions about this trial

What is this clinical trial studying?

A study testing Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CART) in people with Anger Problems and Aggression, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Vanessa Jacoby, PhD ((254) 289-3468, jacobyv@uthscsa.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Successful recruitment (time frame: Study start to last subject enrolled, approximately 1 year). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in